Epidemiological aspects of malignant melanoma of the uvea in tunisia.
##plugins.themes.academic_pro.article.main##
Abstract
SUMMARY
Background: to assess clinical factors that may influence the prognosis of malignant melanoma of the uvea
Methods: We conducted a retrospective study from January 1990 to December 2013, involving 80 patients suffering from malignant melanoma of the uvea. We determined the location, the size, the tumor thickness, the clinicopathological aspect, the degree of pigmentation of the uveal melanoma, and associated signs
Results: Factors significantly associated with poor prognosis were: a tumor location (p = 0.01), the infiltrative or fungus aspect (p = 0.001), a diameter equal to or larger than 10 mm (p = 0.003), the thickness greater than or equal to 5 mm (p = 10-3), achromatic or hyperpigmented melanomas (p = 0.02) and retinal detachment (p = 10-3).
Conclusion: Clinical prognostic factors are important to know because they determine the evolutionary profile and the metastatic potential of the uveal melanoma.
Background: to assess clinical factors that may influence the prognosis of malignant melanoma of the uvea
Methods: We conducted a retrospective study from January 1990 to December 2013, involving 80 patients suffering from malignant melanoma of the uvea. We determined the location, the size, the tumor thickness, the clinicopathological aspect, the degree of pigmentation of the uveal melanoma, and associated signs
Results: Factors significantly associated with poor prognosis were: a tumor location (p = 0.01), the infiltrative or fungus aspect (p = 0.001), a diameter equal to or larger than 10 mm (p = 0.003), the thickness greater than or equal to 5 mm (p = 10-3), achromatic or hyperpigmented melanomas (p = 0.02) and retinal detachment (p = 10-3).
Conclusion: Clinical prognostic factors are important to know because they determine the evolutionary profile and the metastatic potential of the uveal melanoma.
Keywords:
Malignant melanoma of the uvea; clinic aspect ; prognosis##plugins.themes.academic_pro.article.details##
References
- Damato EM, Damato BE. Detection and time to treatment of uveal melanoma in the United Kingdom: an evaluation of 2,384 patients. Ophthalmology. 2012; 119:1582-9.
- McLaughlin CC, Wu XC, Jemal A, and al. Incidence of noncutaneous melanomas in the U. S. Cancer. 2005;103:1000-7.
- Lund RW. The Collaborative Ocular Melanoma Study, mortality by therapeutic approach, age and tumor size. J Insur Med. 2013;43:221-6.
- Shields CL, Furuta M, Thangappan A. Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes. Arch Ophthalmol. 2009;127:989-98
- Desjardins L, Levy-Gabriel C, Lumbroso-Lerouic L, et al. Facteurs pronostiques du mélanome malin de l'uvée. J Fr Ophtalmol. 2006; 297:741-9.
- D'Hermies F. Aspects macroscopiques et histopronostiques du mélanome malin choroïdien. J Fr Ophtalmol. 2007; 301:99-107.
- Isager P, Ehlers N, Overgaard J. Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas. Acta OphthalmolScand. 2004; 82:517-25.
- Kujala E, Mäkitie T, Kivelä T. Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci. 2003;44:4651-9.
- Gambrelle J, Kodjikian L, Rouberol F, et al. Mélanomes uvéaux impliquant le corps ciliaire. Analyse de la survie après protonthérapie ou bêta-curiethérapie par ruthénium-106.À propos de 106 cas. J Fr Ophtalmol. 2004; 27:40-7.
- Kivela T, Eskelin S, Makitie T, and al. Exudative retinal detachment from malignant uveal melanoma: predictors and prognostic significance. Invest Ophthalmol Vis Sci. 2001; 42 :2085-93.
- Papastefanou VP, Cohen VM. Uveal melanoma. J Skin Cancer. 2011; 11:57-74.
- Damato BE, Coupland SE. Ocular melanoma. Saudi J Ophthalmol. 2012; 26:137-44.
- Jovanovic P, Mihajlovic M, Djordjevic-Jocic J, and al. Ocular melanoma: an overview of current status. Int J Clin Exp Pathol. 2013; 6:1230-44.